N-[2-(diethylamino)ethyl]-4-[[4-(4-fluoro-2-phenylmethoxyphenyl)pyrimidin-2-yl]amino]benzamide
C30H32FN5O2 — CID 171343903
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-(diethylamino)ethyl]-4-[[4-(4-fluoro-2-phenylmethoxyphenyl)pyrimidin-2-yl]amino]benzamide
N-[2-(diethylamino)ethyl]-4-[[4-(4-fluoro-2-phenylmethoxyphenyl)pyrimidin-2-yl]amino]benzamide (PubChem CID 171343903) has the molecular formula C30H32FN5O2 and a molecular weight of 513.62 g/mol. Its IUPAC name is N-[2-(diethylamino)ethyl]-4-[[4-(4-fluoro-2-phenylmethoxyphenyl)pyrimidin-2-yl]amino]benzamide.
Molecular Properties
| Compound Name | N-[2-(diethylamino)ethyl]-4-[[4-(4-fluoro-2-phenylmethoxyphenyl)pyrimidin-2-yl]amino]benzamide |
|---|---|
| PubChem CID | 171343903 |
| Molecular Formula | C30H32FN5O2 |
| Molecular Weight | 513.62 g/mol |
| Exact Mass | 513.25 |
| IUPAC Name | N-[2-(diethylamino)ethyl]-4-[[4-(4-fluoro-2-phenylmethoxyphenyl)pyrimidin-2-yl]amino]benzamide |
| SMILES | CCN(CC)CCNC(=O)c1ccc(Nc2nccc(-c3ccc(F)cc3OCc3ccccc3)n2)cc1 |
| InChI | InChI=1S/C30H32FN5O2/c1-3-36(4-2)19-18-32-29(37)23-10-13-25(14-11-23)34-30-33-17-16-27(35-30)26-15-12-24(31)20-28(26)38-21-22-8-6-5-7-9-22/h5-17,20H,3-4,18-19,21H2,1-2H3,(H,32,37)(H,33,34,35) |
| InChIKey | UQJTZVKNDAEHNW-UHFFFAOYSA-N |
| XLogP | 5.68 |
| TPSA | 79.38 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 513.62 |
| LogP ≤ 5 | 5.68 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171343903 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.